Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a Three Dimensional Functional Metabolic Imaging and Risk Assessment System in Classifying Women for Likelihood of Breast Cancer

NCT03296683 is registered in ClinicalTrials.gov with Real Imaging Ltd. as lead sponsor.

NCT NCT03296683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03296683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a Three Dimensional Functional Metabolic Imaging and Risk Assessment System in Classifying Women for Likelihood of Breast Cancer
Lead sponsor
Real Imaging Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
May 23, 2017
Completion date
September 30, 2021
Enrollment
1,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer